Baby formula recalled over bacterial contamination concerns

A manufacturer has recalled certain batches of two infant formula powders following fears that the products could be contaminated with bacteria.

Infant formula
Cronobacter sakazakii can cause fever and diarrhoea and in severe cases may lead to sepsis or meningitis

The UK Food Standards Agency (FSA) this week (January 3) said that manufacturer Reckitt had recalled two infant formula powders as a “precautionary step” because of the “possible presence of Cronobacter sakazakii”.

The affected products - Nutramigen LGG stage 1 and stage 2 Hypoallergenic Formula powders - are foods used for “special medical purposes” for infants that are mainly prescribed but are also available without a prescription, it added.

Read more: Boots baby formula ads breached marketing rules, finds watchdog

The FSA warned that symptoms caused by Cronobacter sakazakii usually include fever and diarrhoea and in severe cases may lead to sepsis or meningitis.

Reckitt has contacted all stores and pharmacies that are supplying these products and issued a recall notice to its customers, it added. 

“Thorough investigation”

The Reckitt recall notice, shared by the FSA, said that the recall was “due to an isolated overseas sample of the product testing positive for Cronobacter sakazakii” and will take place while the manufacturer continues to “conduct a thorough investigation”.

It warned patients not to use the batches but to return them to the pharmacy that dispensed them.

“At Reckitt, we are committed to the highest level of quality and safety, and the health and safety of infants is our highest priority,” it added.

A Reckitt spokesperson stressed that the manufacturer's own testing did not identify any positive results for the bacteria but that the voluntary recall is a result of possible contamination in product sampled by an independent party outside the U.S.

Affected products

The products being recalled are:

Nutramigen LGG Stage 1 Hypoallergenic Formula

  • Pack size: 400g
  • Batch code: ZL3F7D
  • Best before: 01 July 2025

Nutramigen LGG Stage 2 Hypoallergenic Formula

  • Pack size: 400g
  • Batch code: ZL3FAA
  • Best before: 01 July 2025

Nutramigen LGG Stage 2 Hypoallergenic Formula

  • Pack size: 400g
  • Batch code: ZL3FDM
  • Best before: 01 July 2025

Read more: Eye gels recalled due to 'possible microbial contamination', MHRA warns

Reckitt’s recall notice confirmed that “no other batches of Nutramigen LGG Stage 1 and stage 2 are affected and these remain safe to use”. 

“No other Nutramigen products in the range are affected”, it added. 

C+D approached Reckitt for comment.

Sign in or register for free

Costanza Potter

Read more by Costanza Potter

Cos Potter joined C+D as its news editor in December 2022 but has been covering primary care news for over five years. After starting out at the pharmacy press in 2019, she worked at a GP title for several years before the pharmacy sector beckoned her back.

Latest from News

‘Don’t sign up!’: LPC chief advises against new smoking service over fees and safety concerns

 
• By 

A new SLA sent out for a local varenicline smoking cessation service means pharmacists who take up the service will be operating at a loss, and result in “clinical risk” if they take up the service.

‘Violently sick’: ‘Predatory’ pharmacist jailed for abusing two patients

 
• By 

A pharmacist who sexually assaulted two patients in pharmacy consultation rooms will serve two years in prison.

Salary Survey: What does community pharmacy think about Hub and Spoke?

 

If you wanted to describe the potential effect of Hub & Spoke as transformational, you’d be right. What the ultimate effect of that transformation might be remains up for debate.

More from Clinical

Flu: ‘No changes’ to eligibility as autumn start dates announced

 
• By 

The government has announced the dates for pharmacies to begin delivering free flu vaccinations in the autumn with no changes made to the eligible cohorts.

Pharmacist suspended for claiming MMR jab causes autism

 
• By 

A fitness-to-practise (FtP) committee has suspended a pharmacist for four months after she shared “misinformation about the MMR vaccination and autism”, which “risked serious harm” to a patient.